{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:41:08Z","timestamp":1787496068915,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.cmi.2017.11.019","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:27:36Z","timestamp":1512523656000},"page":"749-754","source":"Crossref","is-referenced-by-count":26,"title":["Antibacterial prophylaxis with ciprofloxacin for patients with multiple myeloma and lymphoma undergoing autologous haematopoietic cell transplantation: a quasi-experimental single-centre before-after study"],"prefix":"10.1016","volume":"24","author":[{"given":"M.","family":"Yeshurun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Vaxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Shargian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Yahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bishara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Pasvolsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Wolach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lahav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Gurion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Magen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Herscovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Moshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sela-Navon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Naparstek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Rozovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2017.11.019_bib1","unstructured":"National Comprehensive Cancer Network (NCCN). Prevention and Treatment of Cancer-Related Infections. NCCN Guidelines Version 2.2017. Retrieved February 2017 from (http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp#supportive)."},{"key":"10.1016\/j.cmi.2017.11.019_bib2","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.019_bib3","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2017.11.019_bib4","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/cncr.22205","article-title":"Antibiotic prophylaxis in neutropenic patients. New evidence, practical decisions","volume":"107","author":"Leibovici","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2017.11.019_bib5","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bmt.1704423","article-title":"Antibacterial prophylaxis in hematopoietic stem cell transplant recipients: heterogeneity of current clinical practice","volume":"33","author":"Trifilio","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2017.11.019_bib6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1089\/152581601317210999","article-title":"Practices of infection disease prevention and management during hematopoietic cell transplantation: a survey from the European Group for Blood and Marrow Transplantation","volume":"10","author":"Kroger","year":"2001","journal-title":"J\u00a0Hematother Stem Cell Res"},{"key":"10.1016\/j.cmi.2017.11.019_bib7","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbmt.2008.08.008","article-title":"Variation in supportive care practices in hematopoietic cell transplantation","volume":"14","author":"Lee","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.cmi.2017.11.019_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.hemonc.2013.04.001","article-title":"Hematopoietic stem cell transplantation practice variation among centers in the Eastern Mediterranean Region (EMRO): Eastern Mediterranean Bone Marrow Transplantation (EMBMT) group survey","volume":"6","author":"Rasheed","year":"2013","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.cmi.2017.11.019_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10096-005-1278-x","article-title":"Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia","volume":"24","author":"Kern","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.019_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cncr.11044","article-title":"Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin and resistant Escherichia coli","volume":"97","author":"Gomez","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.cmi.2017.11.019_bib11","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/j.amjmed.2005.11.029","article-title":"Fluoroquinolone resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impact","volume":"119","author":"Gasink","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.cmi.2017.11.019_bib12","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/AAC.00060-06","article-title":"Differential effects of levofloxacin and ciprofloxacin on the risk for isolation of quinolone resistant Pseudomonas aeruginosa","volume":"50","author":"Kaye","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2017.11.019_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","article-title":"A\u00a0large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use","volume":"26","author":"Muto","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cmi.2017.11.019_bib14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2017.11.019_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/INF.0b013e31816591be","article-title":"Polymicrobial bloodstream infection in pediatric patients: risk factors, microbiology, and antimicrobial management","volume":"27","author":"Sutter","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.cmi.2017.11.019_bib16","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJMoa044097","article-title":"Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia","volume":"353","author":"Bucaneve","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl.\u00a05","key":"10.1016\/j.cmi.2017.11.019_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ejcsup.2007.06.002","article-title":"Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients","author":"Bucaneve","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cmi.2017.11.019_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.7326\/0003-4819-142-12_Part_1-200506210-00008","article-title":"Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients","volume":"142","author":"Gafter-Gvili","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2017.11.019_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijantimicag.2011.10.009","article-title":"Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial","volume":"39","author":"Vehreschild","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.cmi.2017.11.019_bib20","doi-asserted-by":"crossref","first-page":"e46220","DOI":"10.1371\/journal.pone.0046220","article-title":"The use of intravenous antibiotics at the onset of neutropenia in patients receiving outpatient-based hematopoietic stem cell transplants","volume":"7","author":"Hamadah","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2017.11.019_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.bmt.1705686","article-title":"A\u00a0randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation","volume":"40","author":"Slavin","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.cmi.2017.11.019_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ajh.21855","article-title":"Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial","volume":"85","author":"Eleutherakis-Papaiakovou","year":"2010","journal-title":"Am J Hematol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1730650X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1730650X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T22:18:59Z","timestamp":1561933139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1730650X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1198743X1730650X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2017.11.019","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}